openPR Logo
Press release

Automated Insulin Delivery Systems Market Analysis for Rising Aging Population, Type, Distribution Channel, End-User, Growth Factors and Competitive Landscape till 2031 | Medtronic, Novo Nordisk, Insulet Corporation, Tandem Diabetes Care, Inc

09-30-2024 07:58 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Automated Insulin Delivery Systems Market || 2024-2031

Automated Insulin Delivery Systems Market || 2024-2031

The Automated Insulin Delivery Systems Market is anticipated to reach USD XX billion by 2031 from USD XX billion in 2022, at a CAGR of XX% during the forecast period.

DataM Intelligence has published a new research report on "Automated Insulin Delivery Systems Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. . The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/automated-insulin-delivery-systems-market

Automated insulin delivery (AID) systems are advanced medical devices designed to manage blood glucose levels in individuals with diabetes by automatically delivering the right amount of insulin. These systems combine an insulin pump, a continuous glucose monitor (CGM), and an algorithm that adjusts insulin doses in real-time based on glucose readings. AID systems aim to mimic the natural function of the pancreas, reducing the need for manual insulin injections and improving glucose control. Commonly known as artificial pancreas systems or closed-loop systems, they help prevent hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar), enhancing the quality of life for people with diabetes.

Key Developments:

A recent study on RocketAP, a new automated insulin delivery (AID) algorithm, showed promising results for adolescents with type 1 diabetes, allowing them to stay in range longer after meals, even without taking mealtime (bolus) insulin. Similar to Control-IQ, RocketAP features a unique system that detects unscheduled meals and rapidly delivers bolus insulin to prevent post-meal hyperglycemia. The study utilized Tandem insulin pumps and Dexcom G6 CGMs, yielding impressive outcomes, suggesting a significant step toward a fully closed-loop system. These advancements are expected to drive market growth in the forecast period.

Research Process:

Both primary and secondary data sources have been used in the global Automated Insulin Delivery Systems Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

List of the Key Players in the Automated Insulin Delivery Systems Market:

Medtronic, Novo Nordisk, Insulet Corporation , Tandem Diabetes Care, Inc, Ypsomed AG, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Biocon, Bigfoot Biomedical, Inc. and sanofi-aventis U.S. LLC.

Segment Covered in the Automated Insulin Delivery Systems Market:

By Device Type: Reusable Insulin Pens, Disposable Insulin Pens

By Insulin Pumps: External/ Tethered Pumps, Implanted Insulin pump (IIP), Patch Pumps, Closed-loop insulin pump, Others

By Pen Needles: Standard Pen Needles, Safety Pen Needles, Others

By End-User: Hospitals, Clinics, Homecare, Others

Regional Analysis:

The global Automated Insulin Delivery Systems Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/automated-insulin-delivery-systems-market

Regional Analysis:

The global Automated Insulin Delivery Systems Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Automated Insulin Delivery Systems Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Automated Insulin Delivery Systems manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Automated Insulin Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/automated-insulin-delivery-systems-market

The research study aims to address the following key questions:

➡What is the expected growth rate of the Automated Insulin Delivery Systems Market during the forecast period of 2031?

➡What key factors are driving the Automated Insulin Delivery Systems Market across various regions?

➡Who are the leading vendors in the Automated Insulin Delivery Systems industry, and what strategies contribute to their success?

➡What is the anticipated market scope for the projected period?

➡What major trends are influencing the industry's growth in the coming years?

➡What challenges does the Automated Insulin Delivery Systems Market face?

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Automated Insulin Delivery Systems Market Analysis for Rising Aging Population, Type, Distribution Channel, End-User, Growth Factors and Competitive Landscape till 2031 | Medtronic, Novo Nordisk, Insulet Corporation, Tandem Diabetes Care, Inc here

News-ID: 3671660 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Glucagon-like Peptide 1 (GLP-1) Analogues Market Expansion Till 2033: Eli Lilly's Mounjaro Becomes Top-Selling Weight-Loss Treatment | Most Leading Companies are Eli Lilly and Company, Novo Nordisk A/S, Hanmi Pharm. Co.., Ltd, Amgen Inc., Gm
United States Glucagon-like Peptide 1 (GLP-1) Analogues Market Expansion Till 20 …
Glucagon-like Peptide 1 (GLP-1) Analogues Market reached US$ 62.81 Billion in 2024 and is expected to reach US$ 299.08 Billion by 2033, growing at a CAGR of 17.6 % during the forecast period 2025-2033. DataM Intelligence has released its latest report on the "Glucagon like Peptide 1 (GLP-1) Analogues Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market
United States Obesity Therapeutics Market Growth Analysis 2025 | Pfizer acquired Metsera and clinched a $10 billion deal
United States Obesity Therapeutics Market Growth Analysis 2025 | Pfizer acquired …
global obesity therapeutics market size reached US$ 9.19 Billion in 2023 with a rise of US$ 11.03 Billion in 2024 and is expected to reach US$ 63.75 Billion by 2033, growing at a CAGR of 21.6% during the forecast period 2025-2033. DataM Intelligence has released its latest report on the "Obestity Therapeutics Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The
Germany's Quantum Materials Market to reach US$ 3.39 billion with a CAGR of 13.41% | Exclusive Report by DatamIntelligence 2025
Germany's Quantum Materials Market to reach US$ 3.39 billion with a CAGR of 13.4 …
Germany's Quantum Materials Market reached US$ 1.23 billion in 2024 and is expected to reach US$ 3.39 billion by 2032, growing with a CAGR of 13.41% during the forecast period 2025-2032. Download Free sample report:- https://www.datamintelligence.com/download-sample/automatic-spraying-robot-market?pratik The Germany's Quantum Materials Market report would provide approximately 78 tables, 75 figures, and 235 pages. Recent product Launch:- ✅November 6, 2025: Fraunhofer IAF launched the SmaraQ project integrating UV-light photonic components on a chip to enable
US Single Cell Omics Market Size and Trends 2025-2034: Market Poised for Rapid Growth with USD 28.88 Billion Opportunity in Precision Medicine
US Single Cell Omics Market Size and Trends 2025-2034: Market Poised for Rapid G …
The Global Single Cell Omics Market was valued at US$ 2.4 billion in 2022 and is projected to reach US$ 15.5 billion by 2032, growing at a CAGR of 20.2% during the forecast period.The market growth is driven by the rapid advancements in single-cell sequencing technologies, increasing investment in genomics and precision medicine, and growing applications in oncology, immunology, and neurobiology research. The rising need for high-resolution cellular analysis to

All 5 Releases


More Releases for Insulin

Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin